Premature infants may be born with lung disease and difficulty in breathing. Dexamethasone
(DEX) is used widely for prevention and treatment of such cases. A previous study showed …

Objective Synthetic glucocorticoid dexamethasone (DEX) is frequently used as a therapeutic
agent to lessen the morbidity of chronic lung disease in premature infants. Surprisingly, little …

Developmental glucocorticoid treatment in rats has been shown to cause body and brain
weight decrements concurrent with behavioral alterations. Here, Sprague–Dawley rats were …

We examined for 18 weeks the effect of dexamethasone treatment on learning and memory
impairment produced by hypoxic–ischemic stress at postnatal day 7 in rat in addition to brain …

Background Dexamethasone (DEX), a synthetic glucocorticoid, is commonly used to prevent
or lessen the morbidity of chronic lung disease in preterm infants. However, evidence is now …

In this study, we investigated the effect of dexamethasone on the long-term learning and
memory functions in developing rats. In Sprague-Dawley rat pups, we administered a daily …

Postnatal dexamethasone (Dex) therapy is associated with adverse neurodevelopmental
outcomes, which might be related to its timing of administration. We used time-dated …

Synthetic corticosteroids, such as dexamethasone, are frequently administered to pregnant
women at risk for preterm delivery. Endogenous corticosteroids are essential for normal …

There is growing concern about long-term neurodevelopmental outcomes after neonatal
corticosteroid treatment for chronic lung disease (CLD). Here, we use a protocol with …

Synthetic glucocorticoid dexamethasone (DEX) is frequently used as a therapeutic agent to
lessen the morbidity of chronic lung disease in premature infants. Previous studies …